ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1859

Clonal Relationships Between Tph and Tfh Cells in Patients with SLE and in Murine Lupus

Takanori Sasaki1, John Sowerby2, Yinan Xiao2, Runci Wang2, Pui Lee3, Yujie Qu4, Marc Sze4, Stephen Alves4, Marc Levesque4, Karen Costenbader5 and Deepak Rao6, 1Brigham and Women's Hospital and Harvard Medical School, Brookline, MA, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Boston Children's Hospital, Newton, MA, 4Merck & Co., Inc., Boston, MA, 5Brigham and Women's Hospital/ Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Systemic lupus erythematosus (SLE), T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: T helper cells, including T peripheral helper (Tph) cells and T follicular helper (Tfh) cells, play pivotal roles in promoting B cell activation and autoantibody production in systemic lupus erythematosus (SLE). However, the developmental relationships between Tph and Tfh cells in SLE remain unclear and the extent to which expanded Tph and Tfh cell clones persist over time in SLE patients is unknown. Here we have used T cell receptor (TCR) profiling to track the dynamics and clonal relationships of Tph and Tfh cells in SLE patients and in murine lupus.

Methods: We profiled TCRs of bulk populations of sorted Tph cells, Tfh cells, Tregs, and 4 other comparator CD4 T cell populations from blood of 9 patients with a new diagnosis of SLE, followed across 3 timepoints: diagnosis, 6 months, and 1 year. 10 control donors were analyzed at a single timepoint as well, yielding a total dataset of 498 bulk TCR profiles. We also performed single-cell RNA and TCRseq (scRNA/TCRseq) using samples from 3 of the 9 SLE patients to link TCR characteristics with gene expression features. Additionally, we conducted scRNA/TCRseq of lung and spleen samples from pristane-induced lupus mice at 3 months and 1 year to assess the development of Tph and Tfh cells in this model.

Results: Longitudinal analyses demonstrated a clear persistence of expanded clones over time of Tph and Tfh cells. Analysis of clonal overlap across cell populations demonstrated substantial TCR overlap between Tph and Tfh cells, suggesting a developmental link between these two subsets (Figure 1). scRNAseq of CD4 T cell subsets from SLE patients highlighted specific clusters of TOX+ CXCL13+ IL21+ Tph cells and TOX+ CXCL13+ IL21+ Tfh cells (Figure 2). Repertoire overlap analysis using scTCR data revealed that TOX+ CXCL13+ IL21+ cluster shared TCR repertoires between Tph and Tfh cells, suggesting this cluster may transition between Tph and Tfh states. TCR repertoires of TOX+ CXCL13+ IL21+ cells were consistently observed in the longitudinal TCR data from Tph and Tfh cells. Pseudo-time analysis using the scRNAseq data suggested that Tfh cells may differentiate into Tph cells. scRNAseq from pristane-induced lupus mice revealed Tox+ Il21+ cells robustly expanded in the lungs at 3 months and 1 year. In the spleen, Tox+ Il21+ cluster could be further classified into Pdcd1+ Bcl6+ Cxcr5+ Tfh cluster and Pdcd1+ Cd200+ Il21+ Tph cluster, and these clusters shared TCR repertoires. To evaluate a developmental link between Tph and Tfh cells, we also generated scRNA/TCRseq data from the lungs and spleens of pristane-induced lupus mice in a Cd4Cre Bcl6fl/fl Tfh-deficient strain. As hypothesized, Tfh-deficient mice showed a significant reduction of Tox+ Il21+cluster (Figure 3A). Flow cytometry analysis confirmed that Tph cells were significantly decreased in Cd4Cre Bcl6fl/fl mice, suggesting that Tfh cells are required for the development of Tph cells in this model (Figure 3B).

Conclusion: We found persistent TCR overlap of Tph and Tfh cells across multiple timepoints in early SLE. These findings support a dynamic relationship between Tph and Tfh cells in SLE with likely functional plasticity between these CD4 T cell subsets.

Supporting image 1

Figure 1. TCR repertoire overlap of T cell subsets from longitudinal SLE samples. A representative figure for TCR overlap of 7 memory CD4 T cell subsets across different time points. B. TCR repertoire overlap between CD4 T cell subsets at diagnosis (SLE, n=9)

Supporting image 2

Figure 2. scRNAseq revealed the TOX+ cluster producing CXCL13 and IL_21 in Tph and Tfh. A: UMAP plots of Tph and Tfh from 3 SLE patients. B: CXCL13 and IL21 expression in each cluster. C: DEG analysis between cluster 5 and other clusters. TOX is highly upregulated in cluster 5.

Supporting image 3

Figure 3. Tfh cells are necessary for the development of Tph cells. A: UMAP plots of scRNAseq in pristane-induced lupus mice spleens demonstrated a reduction of Tox+ Il21+ cells in Cd4Cre Bcl6fl/fl Tfh deficient mice. B: Quantification of Tph cells and Tfh cells by flow cytometry using lymph node, spleen, and lung tissue samples.


Disclosures: T. Sasaki: None; J. Sowerby: None; Y. Xiao: None; R. Wang: None; P. Lee: None; Y. Qu: Merck & Co., Inc., 3; M. Sze: Merck & Co., Inc., 3; S. Alves: Merck & Co., Inc., 3; M. Levesque: Merck & Co., Inc., 3; K. Costenbader: Amgen, 2, 5, AstraZeneca, 5, Bain HealthSciences, 2, Bristol-Myers Squibb(BMS), 2, Cabaletta Bio, 2, 5, Exagen, 5, Gilead, 5, Glaxo Smith Kline, 2, 5, Merck, 5; D. Rao: Amgen, 6, AnaptysBio, 2, AstraZeneca, 1, Bristol-Myers Squibb, 2, 5, GlaxoSmithKline, 2, HiFiBio, 2, Janssen, 5, Merck, 5, Scipher Medicine, 2.

To cite this abstract in AMA style:

Sasaki T, Sowerby J, Xiao Y, Wang R, Lee P, Qu Y, Sze M, Alves S, Levesque M, Costenbader K, Rao D. Clonal Relationships Between Tph and Tfh Cells in Patients with SLE and in Murine Lupus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clonal-relationships-between-tph-and-tfh-cells-in-patients-with-sle-and-in-murine-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clonal-relationships-between-tph-and-tfh-cells-in-patients-with-sle-and-in-murine-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology